Cytoreductive Surgery and HIPEC for Regionally Advanced Gallbladder Cancer: a Case Report

Fay Huang; Raphael Shamavonian; David L Morris

doi:10.1007/s13193-022-01634-3

Cytoreductive Surgery and HIPEC for Regionally Advanced Gallbladder Cancer: a Case Report

Indian J Surg Oncol. 2023 Jun;14(Suppl 1):127-130. doi: 10.1007/s13193-022-01634-3. Epub 2022 Aug 29.

Authors

Fay Huang^{1

2}, Raphael Shamavonian^{1

3}, David L Morris^{1

2}

Affiliations

¹ Hepatobilliary and Surgical Oncology Unit, Department of Surgery, St George Hospital, University of New South Wales, Level 3, Clinical Sciences (Pitney) Building, Kogarah, NSW 2217 Australia.
² St George and Sutherland Clinical School, University of New South Wales, Sydney, NSW Australia.
³ School of Medicine, University of Notre Dame, Sydney, NSW Australia.

Abstract

Gallbladder cancer is a rare cancer, associated with an extremely poor prognosis. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is not commonly performed in gallbladder cancer; however, case series have shown prolonged survival time with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gallbladder cancer and no increase in morbidity compared to cytoreductive surgery without hyperthermic intraperitoneal chemotherapy. We present a case of gallbladder cancer with peritoneal metastases in a 60-year-old male who was successfully treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and survived for 4 years following diagnosis.

Keywords: Cytoreductive surgery; Gallbladder cancer; HIPEC; Survival.